Skip to main content
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: Arch Biochem Biophys. 2016 Jun 13;604:63–73. doi: 10.1016/j.abb.2016.06.008

Table 3.

(−)-Rhazinilam and NSC 613241 do not appear to affect each other’s binding to aberrant polymera

Radiolabeled ligand Potential inhibitor Ligand bound/tubulin in aberrant polymer ± SD (% tubulin recovered in pellet)
10 μM (−)-Rhazinilam 0.37 ± 0.053 (37 ± 5.1)
10 μM (−)-Rhazinilam 80 μM NSC 613241 0.32 ± 0.022 (89 ± 6.4)
10 μM NSC 613241 0.15 ± 0.013 (72 ± 5.4)
10 μM NSC 613241 80 μM (−)-rhazinilam 0.16 ± 0.014 (95 ± 5.2)
a

Experimental conditions were as described in the text. In brief, reaction mixtures containing the indicated concentrations of [3H](−)-rhazinilam, [3H]NSC 613241, nonradiolabeled NSC 613241, or nonradiolabeled (−)-rhazinilam were incubated at 22 °C for 30 min, and the polymer was harvested by centrifugation. Protein and radiolabel content of the pellets was determined, and these data were used to calculate the values shown in the Table.